ロード中...
Taq1A polymorphism and medication effects on inhibitory action control in Parkinson disease
BACKGROUND: Dopamine therapy in Parkinson disease (PD) can have differential effects on inhibitory action control, or the ability to inhibit reflexive or impulsive actions. Dopamine agonist (DAAg) medications, which preferentially target D2 and D3 receptors, can either improve or worsen control of i...
保存先:
| 出版年: | Brain Behav |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6043698/ https://ncbi.nlm.nih.gov/pubmed/29856137 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/brb3.1008 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|